Time and dose-dependent activation of p53 serine 15 phosphorylation among cell lines with different radiation sensitivity

International Journal of Radiation Biology

Volumn 83, Issue 4, 2007, Pages 245-257

  Wittlinger, Michael ^a   Grabenbauer, Gerhard G ^a   Sprung, Carl N ^b   Sauer, Rolf ^a   Distel, Luitpold V R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ATM; NBS; p53; Phosphorylation; Radiosensitivity; Ser15

Indexed keywords

PROTEIN P53;

ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; CELL LINE; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ACTIVATION; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOBLASTOID CELL; MOLECULAR CLONING; NIJMEGEN BREAKAGE SYNDROME; PHOSPHORYLATION; PRIORITY JOURNAL; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

CELL LINE; DNA; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LYMPHOCYTES; PHOSPHORYLATION; RADIATION DOSAGE; RADIATION TOLERANCE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

ATAXIA TELANGIECTASIA;

EID: 33947164274     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000701275432     Document Type: Article

References (46)

1. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89(7):1175-1184.
2. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421(6922):499-506.
3. Bohnke A, Westphal F, Schmidt A, El-Awady RA, Dahm-Daphi J. 2004. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. International Journal of Radiation Biology 80(1):53-63.
4. Bryszewska M, Piasecka A, Zavodnik LB, Distel L, Schussler H. 2003. Oxidative damage of Chinese hamster fibroblasts induced by t-butyl hydroperoxide and by X-rays. Biochim Biophys Acta 1621(3):285-291.
5. Burma S, Kurimasa A, Xie G, Taya Y, Araki R, Abe M, Crissman HA, Ouyang H, Li GC, Chen DJ. 1999. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. Journal of Biological Chemistry 274(24):17139-17143.
6. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281(5383):1677-1679.
7. Distel L, Neubauer S, Varon R, Holter W, Grabenbauer G. 2003. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Medical and Pediatric Oncology 41(1):44-48.
8. Distel LV, Neubauer S, Keller U, Sprung CN, Sauer R, Grabenbauer GG. 2006. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiotherapy and Oncology 81(3):257-263.
9. Dulic V, Kaufmann WK,Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76(6):1013-1023.
10. Dumaz N, Meek DW. 1999. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. The Embo Journal 18(24):7002-7010.
11. El-Awady RA, Dikomey E, Dahm-Daphi J. 2001. Heat effects on DNA repair after ionising radiation: Hyperthermia commonly increases the number of non-repaired double-strand breaks and structural rearrangements. Nucleic Acids Research 29(9):1960-1966.
12. Fei P, El-Deiry WS. 2003. P53 and radiation responses. Oncogene 22(37):5774-5783.
13. Foray N, Marot D, Gabriel A, Randrianarison V, Carr AM, Perricaudet M, Ashworth A, Jeggo P. 2003. A subset of ATM-and ATR-dependent phosphorylation events requires the BRCA1 protein. The Embo Journal 22(11):2860-2871.
14. Girard PM, Riballo E, Begg AC, Waugh A, Jeggo PA. 2002. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 21(27):4191-4199.
15. Kaminski BC, Grabenbauer GG, Sprung CN, Sauer R, Distel LV. 2006. Inter-relation of apoptosis and DNA double-strand breaks in patients with multiple primary cancers. European Journal of Cancer Prevention 15(3):274-282.
16. Keller U, Grabenbauer G, Kuechler A, Sprung CN, Muller E, Sauer R, Distel L. 2005. Cytogenetic instability in young patients with multiple primary cancers. Cancer Genetics and Cytogenetics 157(1):25-32.
17. Keller U, Kuechler A, Liehr T, Muller E, Grabenbauer G, Sauer R, Distel L. 2004. Impact of various parameters in detecting chromosomal aberrations by FISH to describe radiosensitivity. Strahlentherapie und Onkologie 180(5):289-296.
18. Kraakman-van der Zwet M, Overkamp WJ, Friedl AA, Klein B, Verhaegh GW, Jaspers NG, Midro AT, Eckardt-Schupp F, Lohman PH, Zdzienicka MZ. 1999. Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts. Mutation Research 434(1):17-27.
19. Kurz EU, Douglas P, Lees-Miller SP. 2004. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. Journal of Biological Chemistry 279(51):53272-53281.
20. Kurz EU, Lees-Miller SP. 2004. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amsterdam) 3(8-9):889-900.
21. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN. 1998. Phosphorylation of p53 serine 15 increases interaction with CBP. Journal of Biological Chemistry 273(49):33048-33053.
22. Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW. 1992. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Molecular and Cellular Biology 12(11):5041-5049.
23. Li M, Luo J, Brooks CL, Gu W. 2002. Acetylation of p53 inhibits its ubiquitination by Mdm2. Journal of Biological Chemistry 277(52):50607-50611.
24. Liu Q, Kaneko S, Yang L, Feldman RI, Nicosia SV, Chen J, Cheng JQ. 2004. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. Journal of Biological Chemistry 279(50):52175-52182.
25. Matsuura S, Kobayashi J, Tauchi H, Komatsu K. 2004. Nijmegen breakage syndrome and DNA double strand break repair by NBS1 complex. Advanced Biophysics 38:65-80.
26. McKay BC, Ljungman M, Rainbow AJ. 1999. Potential roles for p53 in nucleotide excision repair. Carcinogenesis 20(8):1389-1396.
27. Meek DW. 2004. The p53 response to DNA damage. DNA Repair (Amsterdam) 3(8-9):1049-1056.
28. Neubauer S, Arutyunyan R, Stumm M, Dork T, Bendix R, Bremer M, Varon R, Sauer R, Gebhart E. 2002. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiation Research 157(3):312-321.
29. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102(6):849-862.
30. Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC, Rotter V. 2001. Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene 20(5):581-589.
31. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology 10(15):886-895.
32. Saito S, Goodarzi AA, Higashimoto Y, Noda Y, Lees-Miller SP, Appella E, Anderson CW. 2002. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. Journal of Biological Chemistry 277(15):12491-12494.
33. Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ Jr, Appella E, Anderson CW. 2003. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. Journal of Biological Chemistry 278(39):37536-37544.
34. Sandoval C, Swift M. 1998. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Medical and Pediatric Oncology 31(6):491-497.
35. Satyamoorthy K, Chehab NH, Waterman MJ, Lien MC, El-Deiry WS, Herlyn M, Halazonetis TD. 2000. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. Cell Growth & Differentiation 11(9):467-474.
36. Seidemann K, Tiemann M, Henze G, Sauerbrey A, Muller S, Reiter A. 1999. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: Analysis of 19 patients from the BFM trials. Medical and Pediatric Oncology 33(6):536-544.
37. Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91(3):325-334.
38. Shieh SY, Taya Y, Prives C. 1999. DNA damage-inducible phosphorylation of p53 atN-terminal sites including a novel site,Ser20, requires tetramerization. The Embo Journal 18(7):1815-1823.
39. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes & Development 11(24):3471-3481.
40. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T. 1994. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78(4):703-711.
41. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Development 13(2):152-157.
42. Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G, Oren M, Haupt Y. 1999. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. The Embo Journal 18(7):1805-1814.
43. Wistop A, Keller U, Sprung CN, Grabenbauer GG, Sauer R, Distel LV. 2005. Individual Radiosensitivity Does not Correlate with Radiation-Induced Apoptosis in Lymphoblastoid Cell Lines or CD3+ Lymphocytes. Strahlentherapie und Onkologie 181(5):326-335.
44. Xu Y. 2003. Regulation of p53 responses by post-translational modifications. Cell Death and Differentiation 10(4):400-403.
45. Ye R, Bodero A, Zhou BB, Khanna KK, Lavin MF, Lees-Miller SP. 2001. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. Journal of Biological Chemistry 276(7):4828-4833.
46. Zhang Y, Xiong Y. 2001. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292(5523):1910-1915.